Literature DB >> 17056607

Reversion of tumor phenotype in surface transplants of skin SCC cells by scaffold-induced stroma modulation.

Michael J Willhauck1, Nicolae Mirancea, Silvia Vosseler, Alessandra Pavesio, Petra Boukamp, Margareta M Mueller, Norbert E Fusenig, Hans-Jürgen Stark.   

Abstract

Interactions between cancer cells and the tissue microenvironment play an essential role in controlling tumor development and progression. Here, we report that stromal modulation induced by a biodegradable meshwork (Hyalograft 3D) inhibited tumor vascularization and invasion of the locally invasive low-grade malignant human HaCaT-ras II-4 keratinocytes in a surface xenotransplantation assay. The scaffold caused formation of an active granulation tissue that shifted to a fibrotic-type connective tissue with accumulation of myofibroblasts and collagen bundles. Most importantly, in transplants with scaffolds, the epithelial-stromal border was normalized developing an ultrastructurally complete basement membrane (BM) including hemidesmosomes. The observed reversion of the tumor phenotype was not due to decreased tumor cell proliferation but correlated with (i) normalization of epidermal differentiation, (ii) condensation of extracellular matrix (ECM) and (iii) reduction of peritumoral protease activity Furthermore, inhibited invasion was paralleled by eliminated tumor vascularization. This was substantiated by a diminished endothelial VEGF-receptor (VEGFR) expression and, in turn, by a concomitant increase in the ECM components thrombospondin-1 (TSP-1) and endostatin, known to impair angiogenesis. Even in transplants of the metastatic high-grade malignant HaCaT-ras A-5RT3 keratinocytes the anti-invasive effect of the scaffold-modulated stroma prevailed. Tumor vascularization and invasion was reduced and the epithelial tissue partially normalized including formation of stretches of BM. This clearly demonstrates that the scaffold-modulated connective tissue not only blocks tumor invasion but reverts the tumor phenotype. These novel findings underline the controlling function of tumor stroma and open new strategies of cancer therapy by targeting tumor stroma elements.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17056607     DOI: 10.1093/carcin/bgl188

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  8 in total

1.  Revisiting Epithelial Carcinogenesis.

Authors:  Luis Fernando Méndez-López
Journal:  Int J Mol Sci       Date:  2022-07-04       Impact factor: 6.208

2.  Paradoxical Behavior of Oncogenes Undermines the Somatic Mutation Theory.

Authors:  Noemi Monti; Roberto Verna; Aurora Piombarolo; Alessandro Querqui; Mariano Bizzarri; Valeria Fedeli
Journal:  Biomolecules       Date:  2022-04-30

3.  Differential Expression of SPARC in Intestinal-type Gastric Cancer Correlates with Tumor Progression and Nodal Spread.

Authors:  Konrad Franke; Stacy Carl-McGrath; Friedrich-Wilhelm Röhl; Uwe Lendeckel; Matthias Pa Ebert; Marc Tänzer; Matthias Pross; Christoph Röcken
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

4.  The role of fibroblast Tiam1 in tumor cell invasion and metastasis.

Authors:  K Xu; S Rajagopal; I Klebba; S Dong; Y Ji; J Liu; C Kuperwasser; J A Garlick; S P Naber; R J Buchsbaum
Journal:  Oncogene       Date:  2010-08-30       Impact factor: 9.867

5.  Breast cancer by proxy: can the microenvironment be both the cause and consequence?

Authors:  Lone Rønnov-Jessen; Mina J Bissell
Journal:  Trends Mol Med       Date:  2008-12-16       Impact factor: 11.951

6.  11β-Hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects.

Authors:  Ana Tiganescu; Abd A Tahrani; Stuart A Morgan; Marcela Otranto; Alexis Desmoulière; Lianne Abrahams; Zaki Hassan-Smith; Elizabeth A Walker; Elizabeth H Rabbitt; Mark S Cooper; Kurt Amrein; Gareth G Lavery; Paul M Stewart
Journal:  J Clin Invest       Date:  2013-06-03       Impact factor: 14.808

Review 7.  Tumor reversion: a dream or a reality.

Authors:  Avantika Tripathi; Anjali Kashyap; Greesham Tripathi; Joni Yadav; Rakhi Bibban; Nikita Aggarwal; Kulbhushan Thakur; Arun Chhokar; Mohit Jadli; Ashok Kumar Sah; Yeshvandra Verma; Hatem Zayed; Amjad Husain; Alok Chandra Bharti; Manoj Kumar Kashyap
Journal:  Biomark Res       Date:  2021-05-06

8.  Analysis of TP53 gene and particular infrastructural alterations in invasive ductal mammary carcinoma.

Authors:  Corina Elena Mihalcea; Ana Maria Moroşanu; Daniela Murăraşu; Liliana Puiu; Sabin Aurel Cinca; Silviu Cristian Voinea; Nicolae Mirancea
Journal:  Rom J Morphol Embryol       Date:  2020 Apr-Jun       Impact factor: 1.033

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.